Intestinal Perforation in Patients Receiving an Orthtopic Liver Transplantation in the Montpellier University Hospital
Perfogreffe
1 other identifier
observational
60
1 country
1
Brief Summary
Liver transplantation enhances the prognosis of patients with cirrhoses or hepatocellular carcinoma. However some patients develop intestinal perforations for which the prognosis is poor. The aim of the study is to evaluate the risk factors of intestinal perforations using a retrospective study scheme.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 6, 2019
CompletedStudy Start
First participant enrolled
September 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2019
CompletedFirst Posted
Study publicly available on registry
November 29, 2019
CompletedNovember 29, 2019
August 1, 2019
1 day
August 6, 2019
November 25, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Evaluate the total length of stay
Evaluate the total length of stay
1 month
Evaluate the total length of stay
Evaluate the total length of stay
3 months
Evaluate the total length of stay
Evaluate the total length of stay
6 months.
Secondary Outcomes (5)
Evaluate the occurrence of death
1 month, 3 months, 6 months.
Evaluate the total number of complications
1 month, 3 months, 6 months.
Evaluate the number of perforations
1 month, 3 months, 6 months.
Evaluate the quality of life
1 month, 3 months, 6 months.
Evaluate the occurrence of an acute or chronic rejection
1 month, 3 months, 6 months.
Study Arms (2)
Perforation
Perforation
No perforation
No perforation
Interventions
Eligibility Criteria
Patients having received an orthotopic liver transplantation in the Montpellier University Hospital from 2014 to 2019
You may qualify if:
- Patients having received an orthotopic liver transplantation in the Montpellier University Hospital from 2014 to 2019
- for the group Perforation: patients having during the follow-up a complication such as intestinal perforation. The complete list uses the ICD-10 codes for intestinal perforation, esophageal perforation, duodenal perforation etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Montpellierlead
- Université Montpelliercollaborator
Study Sites (1)
Uh Montpellier
Montpellier, 34295, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Fabrizio PANARO, PhD
UH MONTPELLIER
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 6, 2019
First Posted
November 29, 2019
Study Start
September 30, 2019
Primary Completion
October 1, 2019
Study Completion
October 30, 2019
Last Updated
November 29, 2019
Record last verified: 2019-08